Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2022 R21 RFA-CA-21-005 TANG, SINDY KAM-YAN STANFORD UNIVERSITY A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy Active
2022 R21 CA21-003 SCARCELLI, GIULIANO UNIV OF MARYLAND, COLLEGE PARK Stimulated Brillouin Flow Cytometry for biomechanical assessment of metastatic potential Active
2021 R21 RFA-CA-20-017 ZHANG, FANGLIANG UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Targeted degradation of proteins by affinity peptide conjugated ubiquitin (APCU) Active
2021 R21 RFA-CA-20-017 STILL, AMANDA NICOLE HAYMOND GEORGE MASON UNIVERSITY New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions Active
2021 R43 PAR-18-303 ALLEN, JEFFREY KEITH TUMORGEN, INC. Capture and Characterization of Highly Metastatic Cancer Cell Clusters in Transit from Lung Cancer Patient Whole Blood Specimens. Active
2023 R61 RFA-CA-22-001 PRATX, GUILLEM STANFORD UNIVERSITY A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer Active
2022 R33 CA21-004 NORMAN, THOMAS MAXWELL SLOAN-KETTERING INST CAN RESEARCH Systematic characterization of cancer variants using single-cell functional genomics Active
2017 R21 RFA-CA-16-003 WELJIE, AALIM M UNIVERSITY OF PENNSYLVANIA Determining and enhancing metabolite fitness for metabolomics measurements Complete
2001 R21 PAR-99-100 WATT, PAUL M TELETHON INSTITUTE FOR CHILD HEALTH RES MECHANISMS OF GENOMIC INSTABILITY IN CANCER Complete
2003 R21 PAR-01-106 LABAER, JOSHUA HARVARD UNIVERSITY (MEDICAL SCHOOL) FUNCTIONAL PROTEOMICS OF BREAST CANCER Complete
2006 R42 RFA-CA-05-006 BAO, GANG VIVONETICS, INC. IN VIVO GENE DETECTION FOR CANCER ANALYSIS Complete
2009 R21 RFA-CA-08-007 ZHONG, JOHN UNIVERSITY OF SOUTHERN CALIFORNIA MICROFLUIDIC DEVICES FOR MOLECULAR CHARACTERIZATION OF CANCER CELLS AT THE SINGLE Complete
2013 R21 RFA-CA-13-001 CELEDON, ALFREDO ANDRES SCANOGEN, INC. SINGLE MOLECULE MICROARRAYS FOR THE DETECTION OF MUTANT DNA IN BODY FLUIDS Complete
2016 R33 RFA-CA-15-003 WEISSLEDER, RALPH MASSACHUSETTS GENERAL HOSPITAL ANALYSIS OF SCANT CANCER CELLS IN FINE NEEDLE ASPIRATES Complete
2020 R33 RFA-CA-19-020 COOKS, ROBERT GRAHAM PURDUE UNIVERSITY Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer using Pathology Biopsies Complete
2000 R33 PAR-98-067 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES ULTRA-SENSITIVE APPROACH FOR MONITORING GENE PRODUCTION Complete
2002 R33 PAR-99-102 CAPRIOLI, RICHARD M VANDERBILT UNIVERSITY MOLECULAR ANALYSIS OF CANCER--IMAGING MASS SPECTROMETRY Complete
2005 R44 PAR-01-105 BALGLEY, BRIAN M. CALIBRANT BIOSYSTEMS, INC. INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS Complete
2008 R43 RFA-CA-07-041 CHENCHIK, ALEX CELLECTA, INC. ARRAY-ASSISTED INSERTIONAL MUTAGENESIS PLATFORM FOR FORWARD GENETICS OF CANCER Complete
2011 R33 RFA-CA-10-004 GREIS, KENNETH DONALD UNIVERSITY OF CINCINNATI VALIDATION OF MALDI-MS-BASED INHIBITOR SCREENING TECHNOLOGIES FOR CANCER TARGETS Complete
2015 R43 PAR-13-327 LELENTAL, MARK CATASSAYS NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION Complete
2019 R21 RFA-CA-18-002 YAMAMOTO, KEITH ROBERT UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CasCUT&RUN: An in vivo method to analyze locus-specific protein complexes driving transcription of target genes in cancer Complete
2000 R21 PAR-98-067 GAO, XIAOLIAN UNIVERSITY OF HOUSTON PARALLEL SYNTHESIS OF RNA OLIGONUCLEOTIDE MICROARRAYS Complete
2002 R21 PAR-01-106 CHUONG, CHENG-MING UNIVERSITY OF SOUTHERN CALIFORNIA HIGH RESOLUTION MICROARRAY ANALYSIS OF CANCER Complete
2005 R21 RFA-CA-05-002 ELLINGTON, ANDREW D UNIVERSITY OF TEXAS AUSTIN TRANSDUCING TUMOR CELL ANTIGENS TO AMPLICONS Complete
2008 R21 RFA-CA-07-033 LAZAR, MARIA IULIANA VIRGINIA POLYTECHNIC INST AND ST UNIV MICROFLUIDIC MALDI-MS DEVICE FOR HIGH-THROUGHPUT PROTEOMICS & BIOMARKER DISCOVERY Complete
2011 R21 RFA-CA-10-003 KOPELMAN, RAOUL UNIVERSITY OF MICHIGAN MAGNETOROTATION: A RAPID ASSAY FOR SINGLE CELL DRUG SENSITIVITY OF CANCER CELLS Complete
2015 R21 RFA-CA-14-003 GAO, XIAOHU UNIVERSITY OF WASHINGTON CANCER MOLECULAR ANALYSIS USING QUANTUM DOTS Complete
2018 R21 RFA-CA-17-010 ROBLES, FRANCISCO E GEORGIA INSTITUTE OF TECHNOLOGY Stimulated Raman scattering spectroscopic optical coherence tomography (SRS-SOCT) for label-free molecular imaging of brain tumor pathology Complete
1999 R33 PAR-98-067 DOVICHI, NORMAN J UNIVERSITY OF ALBERTA SINGLE CELL PROTEOME PROJECT--CANCER PROGNOSIS Complete
2001 R33 PAR-99-102 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES HIGH THROUGHPUT FTICR FOR MOLECULAR ANALYSIS OF CANCER Complete
2004 R21 PAR-01-106 SIMS, CHRISTOPHER E UNIVERSITY OF CALIFORNIA IRVINE ASSAYING TYROSINE KINASE ACTIVITY: A NEW PARADIGM Complete
2007 R21 RFA-CA-07-015 LINDSAY, STUART ARIZONA STATE UNIVERSITY-TEMPE CAMPUS MAPPING EPIGENETIC MODIFICATIONS AT THE NANOSCALE: APTAMERS FOR MICROSCOPY Complete
2010 R21 RFA-CA-09-006 WU, MINGMING CORNELL UNIVERSITY A 3D MICROFLUIDIC PLATFORM FOR QUANTITATIVE ASSESSMENTS OF TUMOR CELL MIGRATION Complete
2014 R21 RFA-CA-13-001 WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY DIGITAL DETECTION OF TUMOR-DERIVED CIRCULATING METHYLATED DNA Complete
2010 R21 RFA-CA-09-006 SIEGMUND, KIMBERLY D UNIVERSITY OF SOUTHERN CALIFORNIA APPLYING MOLECULAR PHYLOGENY TO PREDICT CLINICAL OUTCOMES IN CANCER Complete
2014 R21 RFA-CA-13-001 CHIU, DANIEL T UNIVERSITY OF WASHINGTON ULTRA-BRIGHT PROBES WITH ULTRA-NARROW EMISSION FOR MOLECULAR AND CELLULAR ANALYSI Complete
2017 R21 RFA-CA-16-001 KRON, STEPHEN J. UNIVERSITY OF CHICAGO Tag-ChIP-MS for analysis of chromatin-level regulation of DNA repair Complete
2001 R21 PAR-99-100 FRANK-KAMENETSKII, MAXIM D BOSTON UNIVERSITY STUDIES OF HEMATOLOGIC MALIGNANCIES BY PNA TECHNOLOGY Complete
2003 R21 PAR-01-106 ANGELETTI, RUTH HOGUE YESHIVA UNIVERSITY PROTEOMICS OF HEPATIC CARCINOGENESIS Complete
2006 R43 RFA-CA-06-006 BEAUDENON, SYLVIE LUCIE AMBION DIAGNOSTICS, INC. ONCOGENIC MICRORNAS IN HPV-INFECTED CERVICAL SAMPLES Complete
2009 R21 RFA-CA-08-007 TAINSKY, MICHAEL A WAYNE STATE UNIVERSITY SERUM BIOMARKERS FOR COLORECTAL CANCER DETECTION Complete
2013 R21 RFA-CA-13-001 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES COMPACT MICROFLUIDIC PET PROBE CONCENTRATOR FOR PRECLINICAL AND IN VITRO IMAGING Complete
2016 R21 RFA-CA-15-004 GARCIA, ANDRES J GEORGIA INSTITUTE OF TECHNOLOGY USHEAR TECHNOLOGY FOR CANCER CELL PURIFICAITON Complete
2000 R33 PAR-98-067 SINGER, ROBERT H YESHIVA UNIVERSITY FISH AND CHIPS--SINGLE CELL EXPRESSION OF CANCER GENES Complete
2002 R33 PAR-99-102 ALBERTSON, DONNA G UNIVERSITY OF CALIFORNIA SAN FRANCISCO AMPLICON PROFILING BY ARRAY CGH Complete
2006 R21 RFA-CA-06-002 WOODS, VIRGIL L UNIVERSITY OF CALIFORNIA SAN DIEGO DXMS-FACILITATED MEMBRANE PROTEIN CONSTRUCT DESIGN/CANCER Complete
2008 R43 RFA-CA-07-039 HANNA, MICHELLE M RIBOMED BIOTECHNOLOGIES, INC. ABSCRIPTION?-BASED CPG METHYLATION ASSAYS FOR EARLY CANCER DETECTION Complete
2011 R43 RFA-CA-10-013 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete
2015 R43 PAR-13-327 MANDECKI, WLODEK PHARMASEQ, INC. SEQUENECE-SPECIFIC DETECTION OF PROTEASES USING ELECTRONIC P-CHIPS IN MULTIPLEX FORMAT Complete

Pages